Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium.
Isa F AshoorSamhar Al-AkashSarah J KizilbashAsha MoudgilDechu P PuliyandaSaritha RanabothuYi ShiVikas R DharnidharkaPublished in: Pediatric transplantation (2024)
In the largest pediatric kidney transplant recipient case series with EBV DNAemia given rituximab to prevent PTLD, rituximab achieved a short-term reduction in DNA load; however, recurrent DNAemia is common.